WHA72.8 - Improving the transparency of markets for medicines, vaccines, and other health products

Overview

Having considered the report by the Director-General on access to medicines and vaccines2 and its annex entitled “draft road map for access to medicines, vaccines, and other health products, 2019–2023” and the report by the Director-General on medicines, vaccines and health products: cancer medicines,3 pursuant to resolution WHA70.12 (2017) on cancer prevention and control in the context of an integrated approach